| [1] |
Bergström G, Persson M, Adiels M,et al. Prevalence of subclinical coronary artery atherosclerosis in the general population[J]. Circulation, 2021, 144(12):916-929. DOI: 10.1161/CIRCULATIONAHA.121.055340.
|
| [2] |
Su C, Lu Y, Wang Z,et al. Atherosclerosis:The involvement of immunity,cytokines and cells in pathogenesis,and potential novel therapeutics[J]. Aging Dis, 2023, 14(4):1214-1242. DOI: 10.14336/AD.2022.1208.
|
| [3] |
|
| [4] |
Medina-Leyte D J, Zepeda-García O, Domínguez-Pérez M,et al. Endothelial dysfunction,inflammation and coronary artery disease:Potential biomarkers and promising therapeutical approaches[J]. Int J Mol Sci, 2021, 22(8):3850. DOI: 10.3390/ijms22083850.
|
| [5] |
Malekmohammad K, Bezsonov E E, Rafieian-Kopaei M. Role of lipid accumulation and inflammation in atherosclerosis:Focus on molecular and cellular mechanisms[J]. Front Cardiovasc Med, 2021(8):707529. DOI: 10.3389/fcvm.2021.707529.
|
| [6] |
Mezentsev A, Bezsonov E, Kashirskikh D,et al. Proatherogenic sialidases and desialylated lipoproteins:35 years of research and current state from bench to bedside[J]. Biomedicines, 2021, 9(6):600. DOI: 10.3390/biomedicines9060600.
|
| [7] |
Maguire E M, Pearce S W A, Xiao Q. Foam cell formation:A new target for fighting atherosclerosis and cardiovascular disease[J]. Vascul Pharmacol, 2019(112):54-71. DOI: 10.1016/j.vph.2018.08.002.
|
| [8] |
Poznyak A V, Nikiforov N G, Markin A M,et al. Overview of OxLDL and its impact on cardiovascular health:Focus on atherosclerosis[J]. Front Pharmacol, 2020(11):613780. DOI: 10.3389/fphar.2020.613780.
|
| [9] |
Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A,et al. Pathophysiology of atherosclerosis[J]. Int J Mol Sci, 2022, 23(6):3346. DOI: 10.3390/ijms23063346.
|
| [10] |
Checkouri E, Blanchard V, Meilhac O. Macrophages in atherosclerosis,first or second row players?[J]. Biomedicines, 2021, 9(9):1214. DOI: 10.3390/biomedicines9091214.
|
| [11] |
Wilson H M. The intracellular signaling pathways governing macrophage activation and function in human atherosclerosis[J]. Biochem Soc Trans, 2022, 50(6):1673-1682. DOI: 10.1042/BST20220441.
|
| [12] |
Chistiakov D A, Melnichenko A A, Myasoedova V A,et al. Mechanisms of foam cell formation in atherosclerosis[J]. J Mol Med(Berl), 2017, 95(11):1153-1165. DOI: 10.1007/s00109-017-1575-8.
|
| [13] |
Afzoon S, Amiri M A, Mohebbi M,et al. A systematic review of the impact of Porphyromonas gingivalis on foam cell formation:Implications for the role of periodontitis in atherosclerosis[J]. BMC Oral Health, 2023, 23(1):481. DOI: 10.1186/s12903-023-03183-9.
|
| [14] |
Zhang J, Xie M, Huang X,et al. The effects of Porphyromonas gingivalis on atherosclerosis-related cells[J]. Front Immunol, 2021(12):766560. DOI: 10.3389/fimmu.2021.766560.
|
| [15] |
Lei L, Li H, Yan F,et al. Porphyromonas gingivalis lipopolysaccharide alters atherosclerotic-related gene expression in oxidized low-density-lipoprotein-induced macrophages and foam cells[J]. J Periodontal Res, 2011, 46(4):427-437. DOI: 10.1111/j.1600-0765.2011.01356.x.
|
| [16] |
Yang Y, He X, Xia S,et al. Porphyromonas gingivalis facilitated the foam cell formation via lysosomal integral membrane protein 2 (LIMP2)[J]. J Periodontal Res, 2021, 56(2):265-274. DOI: 10.1111/jre.12812.
|
| [17] |
Gupta N, Goswami R, Alharbi M O,et al. TRPV4 is a regulator in P. gingivalis lipopolysaccharide-induced exacerbation of macrophage foam cell formation[J]. Physiol Rep, 2019, 7(7):e14069. DOI: 10.14814/phy2.14069.
|
| [18] |
Nomura M, Liu J, Yu Z X,et al. Macrophage fatty acid oxidation inhibits atherosclerosis progression[J]. J Mol Cell Cardiol, 2019(127):270-276. DOI: 10.1016/j.yjmcc.2019.01.003.
|
| [19] |
Chen W, Wu X, Hu J,et al. The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2,COL1A1,CPT1A,FBP1,DGAT2,and SMAD7[J]. Cardiovasc Diabetol, 2024, 23(1):21. DOI: 10.1186/s12933-024-02119-z.
|
| [20] |
Shen Y, Lin L, Yu W,et al. Expression of carnitine palmitoyltransferase Ⅰ isotypes in gingival tissues of human periodontitis[J]. Int Dent J, 2025, 75(4):100837. DOI: 10.1016/j.identj.2025.100837.
|
| [21] |
Ruan Q, Guan P, Qi W,et al. Porphyromonas gingivalis regulates atherosclerosis through an immune pathway[J]. Front Immunol, 2023(14):1103592. DOI: 10.3389/fimmu.2023.1103592.
|
| [22] |
Xie M, Tang Q, Nie J,et al. BMAL1-downregulation aggravates porphyromonas gingivalis-induced atherosclerosis by encouraging oxidative stress[J]. Circ Res, 2020, 126(6):e15-e29. DOI: 10.1161/CIRCRESAHA.119.315502.
|
| [23] |
Park S, Kim I, Han S J,et al. Oral Porphyromonas gingivalis infection affects intestinal microbiota and promotes atherosclerosis[J]. J Clin Periodontol, 2023, 50(11):1553-1567. DOI: 10.1111/jcpe.13864.
|
| [24] |
Rho J H, Kim H J, Joo J Y,et al. Periodontal pathogens promote foam cell formation by blocking lipid efflux[J]. J Dent Res, 2021, 100(12):1367-1377. DOI: 10.1177/00220345211008811.
|
| [25] |
Palm C L, Nijholt K T, Bakker B M,et al. Short-chain fatty acids in the metabolism of heart failure:Rethinking the fat stigma[J]. Front Cardiovasc Med, 2022(9):915102. DOI: 10.3389/fcvm.2022.915102.
|
| [26] |
Shu H, Hang W, Peng Y,et al. Trimetazidine attenuates heart failure by improving myocardial metabolism via AMPK[J]. Front Pharmacol, 2021(12):707399. DOI: 10.3389/fphar.2021.707399.
|
| [27] |
|
| [28] |
Hu A, Wang H, Xu Q,et al. A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancer[J]. Redox Biol, 2023(68):102959. DOI: 10.1016/j.redox.2023.102959.
|
| [29] |
Gu L, Surolia R, Larson-Casey J L,et al. Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling[J]. Cell Death Differ, 2022, 29(1):118-132. DOI: 10.1038/s41418-021-00840-w.
|
| [30] |
Pourteymour S, Fan J, Majhi R K,et al. PIEZO1 targeting in macrophages boosts phagocytic activity and foam cell apoptosis in atherosclerosis[J]. Cell Mol Life Sci, 2024, 81(1):331. DOI: 10.1007/s00018-024-05372-3.
|
| [31] |
Pan X, Xu H, Ding Z,et al. Guizhitongluo Tablet inhibits atherosclerosis and foam cell formation through regulating Piezo1/NLRP3 mediated macrophage pyroptosis[J]. Phytomedicine, 2024(132):155827. DOI: 10.1016j.phymed.2024.155827.
|